LDOC1 Antikörper

Produktnummer ABIN2430377

Produktdetails anti-LDOC1 Antikörper

Target: LDOC1 (Leucine Zipper, Down-Regulated in Cancer 1 (LDOC1))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LDOC1 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC), ELISA

Aufreinigung: Affinity purification

Immunogen: Recombinant protein of human LDOC1

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IHC 1:50-1:200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.4 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Konservierungsmittel: Sodium azide

Handhabung: Avoid freeze / thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu LDOC1

Target: LDOC1 (Leucine Zipper, Down-Regulated in Cancer 1 (LDOC1))

Andere Bezeichnung: LDOC1 (LDOC1 Produkte)

Synonyme: BCUR1 antikoerper, Mar7 antikoerper, Mart7 antikoerper, RGD1565644 antikoerper, Gm366 antikoerper, LDOC1 antikoerper, LDOC1, regulator of NFKB signaling antikoerper, regulator of NFKB signaling antikoerper, LDOC1 antikoerper, Ldoc1 antikoerper

Hintergrund: The protein encoded by this gene contains a leucine zipper-like motif and a proline-rich region that shares marked similarity with an SH3-binding domain. The protein localizes to the nucleus and is down-regulated in some cancer cell lines. It is thought to regulate the transcriptional response mediated by the nuclear factor kappa B (NF-kappaB). The gene has been proposed as a tumor suppressor gene whose protein product may have an important role in the development and/or progression of some cancers.